| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/17/1994 | WO1993025240A3 Pretargeting methods and compounds |
| 02/17/1994 | WO1993025191A3 Bioresorbable polymer microspheres free from surface active agents, their preparation and application as drug |
| 02/17/1994 | WO1993022332A3 Recombinant production of immunoglobulin-like domains in prokaryotic cells |
| 02/17/1994 | DE4226531A1 Taktventil zur diskontinuierlichen Dosierung eines Volumenstroms Impulse valve for intermittent dosage of a volume flow |
| 02/17/1994 | CA2489978A1 Human growth hormone aqueous formulation |
| 02/17/1994 | CA2141673A1 Non-peptidyl moiety-conjugated cd4-gamma2 and cd4-igg2 immunoconjugates, and uses thereof |
| 02/17/1994 | CA2141581A1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems |
| 02/17/1994 | CA2140133A1 Copolymers of polyaspartic acid |
| 02/17/1994 | CA2120511A1 Pharmaceutical and/or cosmetic composition and the use thereof |
| 02/17/1994 | CA2120345A1 Vaginal mucoadhesive gel, medicament containing it and its method of preparation |
| 02/17/1994 | CA2120248A1 Compounds which can be retained in brain |
| 02/16/1994 | EP0583024A1 Pressurized gas dispensor for inhalationsmedicament |
| 02/16/1994 | EP0582834A1 Pharmaceutical compositions containing esters of omega-3 polyunsatured acids and their use in the topical treatment of morbid affections |
| 02/16/1994 | EP0582727A1 Transdermal therapeutic formulation |
| 02/16/1994 | EP0582595A1 Novel antibodies, and methods for their use |
| 02/16/1994 | CN1082110A Isolation and cloning of a protein with tyrosine-phosphatase activity |
| 02/16/1994 | CN1081910A Chinese-medicinal peptone preparation |
| 02/16/1994 | CN1081909A Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 02/16/1994 | CN1081877A Spheronization process using charged resins |
| 02/16/1994 | CN1023800C Improvements in pharmaceutically acceptable salts |
| 02/16/1994 | CN1023788C Production method for silicon dioxide |
| 02/16/1994 | CN1023765C Sustained release matrix fomulations |
| 02/15/1994 | US5286850 Antibody DTPA-type ligand conjugates |
| 02/15/1994 | US5286846 Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides |
| 02/15/1994 | US5286810 Polyaspartic acid salts from hydrolysis of polysuccinimides |
| 02/15/1994 | US5286647 Human-human hybridomas for neoplasms |
| 02/15/1994 | US5286637 Biologically active drug polymer derivatives and method for preparing same |
| 02/15/1994 | US5286629 Using product with residue of rhamnose, galactose, or galactose 6-phosphate |
| 02/15/1994 | CA1327010C Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production |
| 02/15/1994 | CA1327009C Pharmaceutical composition for oral administration, based on a diphosphonic acid derivative |
| 02/15/1994 | CA1327006C Process for preparing a retard product containing diltiazem for a single daily administration |
| 02/15/1994 | CA1327004C Stabilized pharmaceutical composition and method of producing same |
| 02/15/1994 | CA1327001C Topically active compositions of double-stranded rnas |
| 02/15/1994 | CA1326995C Cyclosporin compositions |
| 02/14/1994 | CA2103635A1 Aqueous dispersions of zein and preparations thereof |
| 02/12/1994 | CA2100692A1 Pharmaceutical compositions containing esters of w-3 polyunsatured acids and their use in the topical treatment of morbid affections |
| 02/09/1994 | EP0582503A1 Composition formed of an aqueous dispersion of stabilized vesicles of amphiphilic non-ionic lipids |
| 02/09/1994 | EP0582502A1 Transdermal composition containing alfuzosin |
| 02/09/1994 | EP0582458A1 Compositions for the topical administration of spironolactone |
| 02/09/1994 | EP0582396A1 Taste-masking composition of bitter pharmaceutical agents |
| 02/09/1994 | EP0582239A1 Pharmaceutical and/or cosmetic preparation and the use of such a preparation |
| 02/09/1994 | EP0582186A1 Process for producing solid pharmaceutical dosage forms with an extended two-stage release |
| 02/09/1994 | EP0582169A2 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form |
| 02/09/1994 | EP0582065A1 1-Oxohydrocarbyl-substituted azacyclohexanes compositions used as acid catalyst |
| 02/09/1994 | EP0582026A1 Condom lubricants |
| 02/09/1994 | EP0581842A1 An organ specific emulsion |
| 02/09/1994 | EP0366770B1 Liposomes coupled to hormones |
| 02/09/1994 | CN1081688A 5,10-methylentetrahydrofolic acid-cyclodextrin inclusion compounds |
| 02/08/1994 | US5284935 Major histocompatibility complex |
| 02/08/1994 | US5284934 Separating a hemmagglutinin-coupled polyoxyethylene or -propylene glycol from a carbohydrate by chromatography; purification; nontoxic immunomodulators |
| 02/08/1994 | US5284871 Oxygen removal |
| 02/08/1994 | US5284833 Aqueous solution or dry concentrate of a surfactant, an osmotic adjuster and a buffer; nontoxic; biocompatability |
| 02/08/1994 | US5284830 Stimulating cartilage repair |
| 02/08/1994 | US5284657 Oligopeptide in cosolvent system fo alcohol and transport enhancing essential oil or acid |
| 02/08/1994 | US5284645 Stable, biocompatible |
| 02/08/1994 | US5284644 Functionalized polyamine chelants and rhodium complexes thereof for conjugation to antibodies |
| 02/08/1994 | US5284588 Method and system for allowing increased migration across a lipid bilayer |
| 02/08/1994 | CA1326820C Percutaneous absorption promoting agent and dermatologic preparation containing the same |
| 02/08/1994 | CA1326816C Water-insolubilized cytokines |
| 02/07/1994 | CA2101790A1 Agents having a physiological cooling effect and active compounds which are suitable for these agents |
| 02/06/1994 | CA2101868A1 Granulocyte-binding antibody constructs, their preparation and use |
| 02/06/1994 | CA2101680A1 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form |
| 02/03/1994 | WO1994002589A1 Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity |
| 02/03/1994 | WO1994002518A1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 02/03/1994 | WO1994002517A1 Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
| 02/03/1994 | WO1994002506A1 Peptide compounds |
| 02/03/1994 | WO1994002450A1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours |
| 02/03/1994 | WO1994002178A1 Targeting of liposomes to the blood-brain barrier |
| 02/03/1994 | WO1994002177A1 Method of preparation of inclusion compounds of nimesulide with cyclodextrins |
| 02/03/1994 | WO1994002176A1 Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether |
| 02/03/1994 | WO1994002174A1 Immunocomplex |
| 02/03/1994 | WO1994002148A1 Novel bioactive compositions, preparation and use thereof |
| 02/03/1994 | WO1994002147A1 Water-dispersible tablets |
| 02/03/1994 | WO1994002122A1 Lymphatic delivery composition |
| 02/03/1994 | WO1994002121A1 Cross-linked polyhydroxylic material for enzymatically controlled drug release |
| 02/03/1994 | WO1994002119A1 Percutaneously administrable base composition and drug composition prepared therefrom |
| 02/03/1994 | WO1994002117A1 Cold cream used in oxidative hair dyes and hair bleaching compositions |
| 02/03/1994 | WO1994002113A1 Industrial, pharmaceutical and cosmetic applications for cultured plant cell gums |
| 02/03/1994 | WO1994002106A1 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 02/03/1994 | WO1994002068A1 System of drug delivery to the lymphatic tissues |
| 02/03/1994 | CA2141216A1 Targeting of liposomes to the blood-brain barrier |
| 02/03/1994 | CA2141193A1 Industrial, pharmaceutical and cosmetic applications for cultured plant cell gums |
| 02/03/1994 | CA2140901A1 Basal drug composition for percutaneous administration and pharmaceutical composition thereof |
| 02/03/1994 | CA2140630A1 Novel bioactive compositions, preparation and use thereof |
| 02/03/1994 | CA2140333A1 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 02/03/1994 | CA2138952A1 Cold mix emulsions used as a developer composition for oxidative hair dyes and for hair bleaches |
| 02/03/1994 | CA2120023A1 Immunoconjugate |
| 02/02/1994 | EP0581676A2 Agglomerated hydrophilic complexes with multi-phasic release characteristics |
| 02/02/1994 | EP0581587A2 Base for transdermal administration |
| 02/02/1994 | EP0581581A2 Bioadhesive treatment compositions and methods of use |
| 02/02/1994 | EP0580861A1 Capsule |
| 02/02/1994 | EP0580803A1 Antimicrobial compositions useful for medical applications |
| 02/02/1994 | EP0580778A1 Convertible microemulsion formulations |
| 02/02/1994 | EP0580763A1 Compositions and methods for endothelial binding |
| 02/02/1994 | EP0580689A1 Improved retard systems for delayed release of medical and/or biological valuable substances from a depot-carrier material. |
| 02/02/1994 | EP0580658A1 Nabumetone powders |
| 02/02/1994 | EP0523183B1 Microspheres, a preparation method therefor and uses thereof |
| 02/02/1994 | EP0464077B1 Process for the preparation of a ligand-receptor complex |
| 02/02/1994 | EP0442958B1 Pharmaceutical composition for ophthalmic use comprising a water soluble acid addition salt of ibopamine |
| 02/02/1994 | EP0378657B1 Oxazolidinone penetration enhancing compounds |